Noninvasive Positive Pressure Ventilation Treatment for Acute Respiratory Failure in SARS

 

 Buy Article Permissions and Reprints

This study describes the blood gases features and short-term outcomes with noninvasive positive pressure ventilation (NPPV) treatment in the management of acute respiratory failure (ARF) during a severe acute respiratory syndrome (SARS) epidemic. Between April 22 and May 1, 2003, 120 patients meeting clinical criteria for SARS were admitted to a hospital for infectious diseases in Beijing, China. At 6 weeks after onset, 25% of patients (30/120) had experienced ARF. Of interest, 16 of these patients (53%) exhibited hypercapnia (PaCO₂ > 45 mm Hg), and 10 hypercapnic events occurred within 1 week of admission. The occurence of hypencapnia or CO₂ retention and was accompanied by myalgias. NPPV was instituted in 28 patients; one was intolerant of NPPV. In the remaining 27 patients, NPPV was initiated 1.2 ± 1.6 days after ARF onset. An hour of NPPV therapy led to significant increases in PaO₂ and PaO₂/FiO₂ and a decrease in respiratory rate (p < 0.01). Endotracheal intubation was required in one third of the patients (9 of 27) who initially had a favorable response to NPPV. Remarkable pulmonary barotrauma was noticed in 7 of all 120 patients (5.8%) and in 6 of those (22%) on NPPV. The overall fatality rate at 13 weeks was 6.7% (8/120); it was higher (26.7%) in those needing NPPV. No caregiver contracted SARS. We conclude that NPPV is a feasible and appropriate treatment for ARF occurring as a result of a SARS infection.

REFERENCES

• 1 Peiris J S, Chu C M, Cheng V C et al.. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.  Lancet. 2003;  361 1767-1772
  CrossrefPubMedGoogle Scholar
• 2 Lew T W, Kwek T K, Tai D et al.. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.  JAMA. 2003;  290 374-380
  CrossrefPubMedGoogle Scholar
• 3 Fowler R A, Lapinsky S E, Hallett D et al.. Critically ill patients with severe acute respiratory syndrome.  JAMA. 2003;  290 367-373
  CrossrefPubMedGoogle Scholar
• 4 Booth C M, Matukas L M, Tomlinson G A et al.. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.  JAMA. 2003;  289 2801-2809
  CrossrefPubMedGoogle Scholar
• 5 Bott J, Carroll M P, Conway J H et al.. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.  Lancet. 1993;  341 1555-1557
  CrossrefPubMedGoogle Scholar
• 6 Antonelli M, Conti G, Bufi M et al.. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial.  JAMA. 2000;  283 235-241
  CrossrefPubMedGoogle Scholar
• 7 Conti G, Marino P, Cogliati A et al.. Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study.  Intensive Care Med. 1998;  24 1283-1288
  CrossrefPubMedGoogle Scholar
• 8 Confalonieri M, Calderini E, Terraciano S et al.. Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia.  Intensive Care Med. 2002;  28 1233-1238
  CrossrefPubMedGoogle Scholar
• 9 Hilbert G, Gruson D, Vargas F et al.. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.  N Engl J Med. 2001;  344 481-487
  CrossrefPubMedGoogle Scholar
• 10 Liu X Q, Li Y M, Zhong N S et al.. Management of severe acute respiratory syndrome and risk factors for death [in Chinese].  Zhonghua Jie He He Hu Xi Za Zhi. 2003;  26 329-333
  PubMedGoogle Scholar
• 11 Lapinsky S E, Hawryluck L. ICU management of severe acute respiratory syndrome.  Intensive Care Med. 2003;  29 870-875
  PubMedGoogle Scholar
• 12 Chinese Thoracic Society . Consensus on the diagnosis and treatment of severe acute respiratory syndrome [in Chinese].  Zhonghua Jie He He Hu Xi Za Zhi. 2003;  26 323-324
  PubMedGoogle Scholar
• 13 Centers for Disease Control and Prevention .SARS http://www.cdc.gov/mmwr/preview/mmwrhtml/mm52d429a1.htm (accessed January 15, 2004)
• 14 Gao J. Summary of the Cross-Strait seminar on prevention and control of SARS.  Zhonghua Yi Xue Za Zhi. 2003;  83 708-712
  PubMedGoogle Scholar
• 15 Nicholls J M, Poon L L, Lee K C et al.. Lung pathology of fatal severe acute respiratory syndrome.  Lancet. 2003;  361 1773-1778
  CrossrefPubMedGoogle Scholar
• 16 Lee N, Hui D, Wu A et al.. A major outbreak of severe acute respiratory syndrome in Hong Kong.  N Engl J Med. 2003;  348 1986-1994
  CrossrefPubMedGoogle Scholar
• 17 Bone R C, Maunder R, Slotman G et al.. An early test of survival in patients with the adult respiratory distress syndrome: the PaO₂/FiO₂ ratio and its differential response to conventional therapy.  Chest. 1989;  96 849-851
  PubMedGoogle Scholar
• 18 Zhong N S, Zeng G Q. Our strategies for fighting severe acute respiratory syndrome (SARS).  Am J Respir Crit Care Med. 2003;  168 7-9
  CrossrefPubMedGoogle Scholar
• 19 Wong K T, Antonio G E, Hui D S et al.. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease.  Radiology. 2003;  228 395-400
  PubMedGoogle Scholar
• 20 Olliff J F, Williams M P. Radiological appearances of cytomegalovirus infections.  Clin Radiol. 1989;  40 463-467
  CrossrefPubMedGoogle Scholar
• 21 Tutor J D, Montgomery V L, Eid N S. A case of influenza virus bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema.  Pediatr Pulmonol. 1995;  19 393-395
  PubMedGoogle Scholar
• 22 Pastores S M, Garay S M, Naidich D P, Rom W M. Review: pneumothorax in patients with AIDS-related Pneumocystis carinii pneumonia.  Am J Med Sci. 1996;  312 229-234
  CrossrefPubMedGoogle Scholar
• 23 Metersky M L, Colt H G, Olson L K, Shanks T G. AIDS-related spontaneous pneumothorax. Risk factors and treatment.  Chest. 1995;  108 946-951
  PubMedGoogle Scholar
• 24 Herrejon S A, Inchaurraga A I, Marin G M. Spontaneous pneumothorax associated with the use of nighttime BiPAP with a nasal mask [in Spanish].  Arch Bronconeumol. 1998;  34 512
  PubMedGoogle Scholar
• 25 Sheehan G J, Miedzinski L J, Schroeder D G. Pneumothorax complicating BiPAP therapy for Pneumocystis carinii pneumonia.  Chest. 1993;  103 1310
  PubMedGoogle Scholar
• 26 McEachern R C, Patel R G. Pneumopericardium associated with face-mask continuous positive airway pressure.  Chest. 1997;  112 1441-1443
  CrossrefPubMedGoogle Scholar
• 27 Choo-Kang L R, Ogunlesi F O, McGrath-Morrow S A, Crawford T O, Marcus C L. Recurrent pneumothoraces associated with nocturnal noninvasive ventilation in a patient with muscular dystrophy.  Pediatr Pulmonol. 2002;  34 73-78
  CrossrefPubMedGoogle Scholar
• 28 Cooney D R, Menke J A, Allen J E. “Acquired” lobar emphysema: a complication of respiratory distress in premature infants.  J Pediatr Surg. 1977;  12 897-904
  CrossrefPubMedGoogle Scholar
• 29 Zhidkov K P, Bogatyr' M N, Chezhin A N, Leiman V A, Smirnova O R. A case of respiratory distress syndrome complicated by the development of interstitial emphysema and pneumomediastinum [in Russian].  Anesteziol Reanimatol. 2000;  3 62-64
  PubMedGoogle Scholar

Fang HanM.D. 

Department of Medicine, the People's Hospital, Beijing University

11#, X; Zhi Men Na Da Jie, Xi Chenqu, Beijing, 100044, China

Email: hanfang1@hotmail.com